D-0752-2022 Class III Terminated
FDA drug recall D-0752-2022 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Apr 1, 2022 and is designated Class III. Reason for recall: Subpotent The recall status is terminated (terminated Apr 3, 2023). Affected quantity: 19,222 Bottles (100-count).
Recall details
- Product Type
- Drugs
- Report Date
- Apr 13, 2022
- Initiation Date
- Apr 1, 2022
- Termination Date
- Apr 3, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,222 Bottles (100-count)
Product description
Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06
Reason for recall
Subpotent
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot # 21 P0322, Exp. 01/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0752-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026